Fatal pulmonary fibrosis following 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy

C C Bailey; H B Marsden; P H Jones

doi:10.1002/1097-0142(197807)42:1<74::aid-cncr2820420111>3.0.co;2-i

Fatal pulmonary fibrosis following 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy

Cancer. 1978 Jul;42(1):74-6. doi: 10.1002/1097-0142(197807)42:1<74::aid-cncr2820420111>3.0.co;2-i.

Authors

C C Bailey, H B Marsden, P H Jones

PMID: 667809
DOI: 10.1002/1097-0142(197807)42:1<74::aid-cncr2820420111>3.0.co;2-i

Abstract

A case is reported of a child with fatal pulmonary fibrosis following BCNU therapy. This side effect has only once previously been reported with the nitrosourea group of compounds.

Publication types

Case Reports

MeSH terms

Carmustine / adverse effects*
Cerebellar Neoplasms / drug therapy*
Female
Humans
Infant
Medulloblastoma / drug therapy*
Pneumonia, Pneumococcal / complications
Pulmonary Fibrosis / chemically induced*
Pulmonary Fibrosis / complications
Pulmonary Fibrosis / pathology

Substances

Carmustine